Complications of blood cancers make termination advisable at early stages of pregnancy

Lymphoma is the fourth most common cancer in pregnancy, affecting one in 6000 pregnancies. Non-Hodgkin lymphoma, acute leukaemia, and other blood cancers, while also rare, can also occur in pregnancy. The need for urgent chemotherapy and the increased risk of blood clots during pregnancy, which is enhanced in blood cancers, mean that it is advisable to terminate a pregnancy if it is in its early stages to protect the health of the mother. However cancers discovered later in pregnancy can be treated. The issues around blood cancers in pregnancy are discussed in the third paper of The Lancet Series on pregnancy in cancer, written by Dr Benjamin Brenner, Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel, and colleagues.

The rarity of these cancers means large-scale trials of any description in pregnant women have been unfeasible, and thus much of the evidence is based on case reports or case series.

A constellation of risk factors coming together makes it advisable for pregnant women with blood cancers (who wish to continue their pregnancy) to undergo thromboprophylaxis with during their pregnancy. The higher risk of clotting during pregnancy and birth is further increased by cancer-related factors and the used to treat cancer. Thromboprophylaxis reduces the risk of deep-vein thrombosis or in the mother, and may also decrease the risk of placental thrombosis, and or death.

The authors advise that, in the absence of a durable remission of at least 2𔃁 years, avoidance of pregnancy is advisable in patients with acute leukaemia or lymphoma because the disease is most likely to recur during that period. Whether there is any association between pregnancy and risk of relapse remains unclear. They add that as combined hormonal contraceptives increase the risk of thrombosis, they are not recommended in patients with active disease but they can be considered for those in long-term remission. However, progesterone-only preparations, either taken orally or as an intrauterine device, are thought to be safe.

Blood cancers in pregnancy, although rare, poses diagnostic and therapeutic challenges. Management should focus on survival of the mother, while minimising treatment-related fetal toxic effects. The authors conclude that the scarcity of data emphasises the need for extensive collaborative efforts to expand basic and clinical research in this important setting.

More information: www.thelancet.com/series/malignancies-in-pregnancy

add to favorites email to friend print save as pdf

Related Stories

Migraines increase stroke risk during pregnancy

Mar 10, 2009

Women who suffer migraines are at an increased risk of stroke during pregnancy as well as other vascular conditions such as heart disease, high blood pressure and blood clots, concludes a study published on bmj.com today.

Recommended for you

Tips, myths surrounding breastfeeding

Sep 30, 2014

Breastfeeding is the method of infant feeding recommended by the Association of Women's Health, Obstetric and Neonatal Nurses, the American Academy of Pediatrics and the American College of Obstetricians and ...

Joint effort in standardizing due date estimation

Sep 23, 2014

(HealthDay)—The American College of Obstetricians and Gynecologists, the American Institute of Ultrasound in Medicine, and the Society for Maternal-Fetal Medicine have jointly released new recommendations ...

AWHONN recommends reducing overuse of labor induction

Sep 23, 2014

The Association of Women's Health, Obstetric and Neonatal Nurses (AWHONN) is calling upon healthcare providers and pregnant women to avoid induction of labor at any time during pregnancy unless it is medically necessary.

User comments